The director of the National Institutes of Health has agreed to follow the recommendations in a working group report that lays out a framework on how to get President Obama's Precision Medicine Initiative off the ground. The report outlines how to create the Precision Medicine Initiative Cohort Program, which he notes has commercial potential for device and diagnostic companies.
Under the initiative announced by the president in his January State of the Union address, a million-plus Americans would be part of a massive research effort to document longitudinal biomedical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?